Qindong Cai
Overview
Explore the profile of Qindong Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu Y, Cai Q, Li J, Guo W, Chen L, Chen M, et al.
Breast Cancer Res Treat
. 2025 Jan;
PMID: 39755988
Purpose: Age stratification influences the clinicopathological features and survival outcomes of breast cancer. We aimed to understand the effect of age on gene variants in young Chinese women with breast...
2.
Chen X, Cai Q, Deng L, Chen M, Xu M, Chen L, et al.
Front Immunol
. 2024 Dec;
15:1465862.
PMID: 39628488
Introduction: The association between inflammatory blood markers (IBMs) (monocyte-to-lymphocyte ratio [MLR], neutrophil-to-lymphocyte ratio [NLR], and platelet-to-lymphocyte ratio [PLR]) and breast cancer has been extensively studied. However, the predictive role of...
3.
Nie Q, Zhang W, Lin S, Huang M, Li Y, Qiu Y, et al.
Cancer Sci
. 2024 Oct;
115(12):4064-4073.
PMID: 39401980
Mitochondrial DNA (mtDNA) variations affect the efficiency of the electron transport chain and production of reactive oxygen species, contributing to carcinogenesis. The D-loop region of mtDNA has emerged as a...
4.
Li J, He P, Cai Q, Chen L, Wang Y, Cai W, et al.
J Cancer Res Clin Oncol
. 2024 Jun;
150(6):322.
PMID: 38914840
Purpose: Limited data are available regarding the partner and localizer of BRCA2 (PALB2) in Chinese patients with early breast cancer. This study aimed to assess the spectrum and characteristics of...
5.
Wang Y, Cai W, He P, Cai Q, Huang J, Liu S, et al.
Int J Cancer
. 2024 Apr;
155(3):545-557.
PMID: 38561936
Recombinant human granulocyte colony-stimulating factor (G-CSF) administration in patients with cancer and coronavirus disease (COVID-19) remains controversial. Concerns exist that it may worsen COVID-19 outcomes by triggering an inflammatory cytokine...
6.
He P, Li J, Chen M, Huang M, Qiu Y, Cai Q, et al.
Breast Cancer Res Treat
. 2023 Oct;
203(1):13-28.
PMID: 37787817
Purpose: Optimal extended adjuvant endocrine therapy (ET) duration and strategy for hormone receptor-positive (HR +) early breast cancer remain unclear. In this network meta-analysis (NMA), the efficacy and safety of...
7.
Chen L, Wu F, Chen X, Chen Y, Deng L, Cai Q, et al.
NPJ Breast Cancer
. 2023 May;
9(1):46.
PMID: 37258524
While overweight/obesity has become a major public health issue worldwide, any association between body mass index (BMI) and therapeutic response in neoadjuvant targeted therapy treated HER2 positive breast cancer patients...
8.
High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients
Zhang W, Lin S, Zeng B, Chen X, Chen L, Chen M, et al.
BMC Cancer
. 2023 Apr;
23(1):377.
PMID: 37098487
Background: Compelling evidence has indicated a significant association between leukocyte mitochondrial DNA copy number (mtDNAcn) and prognosis of several malignancies in a cancer-specific manner. However, whether leukocyte mtDNAcn can predict...